These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9657743

  • 21. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O.
    Blood; 1998 May 15; 91(10):3734-45. PubMed ID: 9573010
    [Abstract] [Full Text] [Related]

  • 22. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr 15; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD, Dostal D, Baker K.
    J Mol Cell Cardiol; 1998 Apr 15; 30(4):751-61. PubMed ID: 9602424
    [Abstract] [Full Text] [Related]

  • 24. Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1 rhabdomyosarcoma cells.
    Storz P, Döppler H, Pfizenmaier K, Müller G.
    FEBS Lett; 1999 Dec 31; 464(3):159-63. PubMed ID: 10618497
    [Abstract] [Full Text] [Related]

  • 25. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
    Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ, Yoshimura A.
    J Biol Chem; 1997 Mar 28; 272(13):8149-52. PubMed ID: 9079629
    [Abstract] [Full Text] [Related]

  • 26. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
    Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nuñez G, Fernandez-Luna JL.
    J Biol Chem; 1999 Aug 06; 274(32):22165-9. PubMed ID: 10428780
    [Abstract] [Full Text] [Related]

  • 27. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F, Towatari M, Iida H, Wakao H, Kiyoi H, Naoe T, Saito H.
    Br J Haematol; 1998 Jun 06; 101(3):521-8. PubMed ID: 9633897
    [Abstract] [Full Text] [Related]

  • 28. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA, Waxman DJ.
    J Biol Chem; 1997 Jul 11; 272(28):17694-702. PubMed ID: 9211920
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL, Pelus LM, Lord KA.
    Stem Cells; 2000 Jul 11; 18(5):366-73. PubMed ID: 11007921
    [Abstract] [Full Text] [Related]

  • 31. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
    Okajima Y, Matsumura I, Nishiura T, Hashimoto K, Yoshida H, Ishikawa J, Wakao H, Yoshimura A, Kanakura Y, Tomiyama Y, Matsuzawa Y.
    J Biol Chem; 1998 Sep 04; 273(36):22877-83. PubMed ID: 9722506
    [Abstract] [Full Text] [Related]

  • 32. STAT1 is involved in signal transduction in the EPO induced HEL cells.
    Chu J, Gui CY, Fan J, Tang XD, Qiao RL.
    Cell Res; 1998 Jun 04; 8(2):105-17. PubMed ID: 9669026
    [Abstract] [Full Text] [Related]

  • 33. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO, Harris KW, Forget BG.
    Exp Hematol; 1999 Jan 04; 27(1):63-74. PubMed ID: 9923445
    [Abstract] [Full Text] [Related]

  • 34. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
    Rui H, Xu J, Mehta S, Fang H, Williams J, Dong F, Grimley PM.
    J Biol Chem; 1998 Jan 02; 273(1):28-32. PubMed ID: 9417042
    [Abstract] [Full Text] [Related]

  • 35. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL.
    J Immunol; 2000 Nov 01; 165(9):5097-104. PubMed ID: 11046040
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER, Pacifici R, Crouse J, Batac J, Todokoro K, Wojchowski DM.
    Blood; 1997 Sep 15; 90(6):2175-87. PubMed ID: 9310468
    [Abstract] [Full Text] [Related]

  • 38. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.
    Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A.
    EMBO J; 1995 Jun 01; 14(11):2527-35. PubMed ID: 7781605
    [Abstract] [Full Text] [Related]

  • 39. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H, Chida D, Damen JE, Krystal G, Miyajima A.
    Biochem Biophys Res Commun; 1997 May 08; 234(1):198-205. PubMed ID: 9168989
    [Abstract] [Full Text] [Related]

  • 40. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells.
    Penta K, Sawyer ST.
    J Biol Chem; 1995 Dec 29; 270(52):31282-7. PubMed ID: 8537396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.